EMEA-002033-PIP01-16-M03
Key facts
| Invented name |
Voxzogo
|
| Active substance |
Vosoritide
|
| Therapeutic area |
Other
|
| Decision number |
P/0453/2022
|
| PIP number |
EMEA-002033-PIP01-16-M03
|
| Pharmaceutical form(s) |
Powder for solution for injection
|
| Condition(s) / indication(s) |
Treatment of achondroplasia
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
BioMarin International Limited
Tel. +44 (0)20 7420 0800 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|